Zenapax and acute pulmonary oedema 
Zenapax and acute pulmonary oedema Patient Reports February 11, 2012
Zenapax Side Effects Report #5735018-X
Zenapax side effect was reported by a Physician from FRANCE on May 06, 2008. Male patient, weighting 94.80 lb, was diagnosed with graft versus host disease, bone marrow transplant
and was treated with Zenapax. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, acute respiratory distress syndrome, toxoplasmosis. Zenapax dosage: unknown. During the same period patient was treated with CELLCEPT, SANDIMMUNE, LOXEN, PLITICAN, VANCOCIN. Patient died on 01/30/2008.Zenapax Side Effects Report #5739228-7
Zenapax side effect was reported by a Physician from FRANCE on Apr 30, 2008. Male patient, weighting 94.80 lb, was diagnosed with graft versus host disease, bone marrow transplant
and was treated with Zenapax. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, acute respiratory distress syndrome, toxoplasmosis. Zenapax dosage: unknown. During the same period patient was treated with CELLCEPT, SANDIMMUNE, LOXEN, PLITICAN, VANCOCIN. Patient died on 01/30/2008.Zenapax Side Effects Report #5746212-6
Zenapax side effect was reported by a Physician from FRANCE on May 16, 2008. Male patient, weighting 94.80 lb, was diagnosed with graft versus host disease, prophylaxis against transplant rejection and was treated with Zenapax. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, acute respiratory distress syndrome, toxoplasmosis. Zenapax dosage: unknown. During the same period patient was treated with CELLCEPT, SANDIMMUNE, LOXEN, PLITICAN, VANCOCIN, FORTUM, CANCIDAS. Patient died on 01/30/2008.
Zenapax Side Effects Report #5729133-4
Zenapax side effect was reported by a Physician from FRANCE on Apr 30, 2008. Male patient, weighting 94.80 lb, was diagnosed with prophylaxis against transplant rejection and was treated with Zenapax. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, acute respiratory distress syndrome, toxoplasmosis. Zenapax dosage: unknown. During the same period patient was treated with CELLCEPT, SANDIMMUNE, LOXEN, PLITICAN, VANCOCIN. Patient died on 01/30/2008.